BAX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	5.43M
Average Volume	3.93M
Market Cap	17.37B
EPS	$0 ( 2024-05-02 )
Next earnings date	( $0.660 ) 2024-07-25
Last Dividend	$0.290 ( 2024-05-31 )
Next Dividend	$0 ( N/A )
P/E	-426.13
ATR14	$0.0260 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-07	Wilver Peter M	Buy	5 952	Common Stock, $1 par value
2024-05-07	Wilkes David S.	Buy	5 952	Common Stock, $1 par value
2024-05-07	Wendell Amy Mcbride	Buy	5 952	Common Stock, $1 par value
2024-05-07	Smith Cathy R	Buy	5 952	Common Stock, $1 par value
2024-05-07	Shafer David Brent	Buy	5 952	Common Stock, $1 par value

INSIDER POWER
76.19
Last 100 transactions
Buy: 1 646 591 \| Sell: 191 040

Volume Correlation

Long: 0.62 (weak)

Short: 0.79 (moderate)

Signal:(70.497) Neutral

Baxter International Inc Correlation

10 Most Positive Correlations
HSHP	0.902
ET-PE	0.872
VLTO	0.869
GIC	0.868
OBDC	0.863
AMBP	0.85
BWLP	0.846
NEE-PR	0.841
FSCO	0.832
RJF-PB	0.831

10 Most Negative Correlations
MKFG-WT	-0.898
YSG	-0.876
ELIQ	-0.868
PHG	-0.864
DAC	-0.854
KDP	-0.854
RM	-0.851
CION	-0.849
AZN	-0.848
GSL	-0.843

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Baxter International Inc Correlation - Currency/Commodity

-0.22
( neutral )

-0.44
( neutral )

0.00
( neutral )

0.48
( neutral )

0.12
( neutral )

Baxter International Inc Financials

Annual	2023
Revenue:	$14.81B
Gross Profit:	$4.98B (33.59 %)
EPS:	$-0.450

FY	2023
Revenue:	$14.81B
Gross Profit:	$4.98B (33.59 %)
EPS:	$-0.450

FY	2022
Revenue:	$15.11B
Gross Profit:	$5.40B (35.71 %)
EPS:	$-4.80

FY	2021
Revenue:	$12.78B
Gross Profit:	$5.11B (39.93 %)
EPS:	$2.52

Financial Reports:

No articles found.

Baxter International Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0.290 (N/A)	$0 (N/A)	$0 (N/A)

Baxter International Inc Dividend Information - Dividend King

Dividend Sustainability Score: 9.60 - good (96.02%) | Divividend Growth Potential Score: 6.93 - Stable (38.62%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0142	1982-03-10
Last Dividend	$0.290	2024-05-31
Next Dividend	$0	N/A
Payout Date	2024-07-01
Next Payout Date	N/A
# dividends	151	--
Total Paid Out	$21.59	--
Avg. Dividend % Per Year	1.62%	--
Score	5.63	--
Div. Sustainability Score	9.60
Div.Growth Potential Score	6.93
Div. Directional Score	8.27	--

Next Divdend (Est)
(2024-07-15)

$0.292 Estimate 73.18 %

Dividend Stability

0.98 Excellent

Dividend Score

5.63

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1982	$0.0568	1.35%
1983	$0.0692	1.21%
1984	$0.0808	1.41%
1985	$0.0908	2.80%
1986	$0.0988	2.59%
1987	$0.108	2.31%
1988	$0.123	2.14%
1989	$0.138	3.17%
1990	$0.158	2.51%
1991	$0.182	2.70%
1992	$0.217	2.25%
1993	$0.272	3.14%
1994	$0.278	4.20%
1995	$0.301	3.94%
1996	$1.296	11.50%
1997	$0.314	2.85%
1998	$0.315	2.32%
1999	$0.315	1.84%
2000	$1.053	6.32%
2001	$0.316	1.30%
2002	$0.316	1.10%
2003	$0.316	2.03%
2004	$0.316	1.93%
2005	$0.316	1.68%
2006	$0.316	1.52%
2007	$0.392	1.55%
2008	$0.495	1.58%
2009	$0.581	1.94%
2010	$0.642	2.03%
2011	$0.686	2.50%
2012	$0.852	3.10%
2013	$1.042	2.84%
2014	$1.112	2.96%
2015	$0.794	1.99%
2016	$0.505	1.36%
2017	$0.610	1.37%
2018	$0.730	1.09%
2019	$0.850	1.30%
2020	$0.955	1.11%
2021	$1.085	1.35%
2022	$1.150	1.32%
2023	$1.160	2.27%
2024	$0.580	1.49%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
ACP	Dividend Royal	2024-05-22	Monthly	14	11.88%	8.50
PVL	Dividend Royal	2023-11-15	Monthly	14	9.37%	8.50
ARR	Dividend Royal	2024-05-14	Monthly	15	11.08%	8.50
ACV	Dividend Royal	2024-06-13	Monthly	10	10.19%	8.50
AVK	Dividend Royal	2024-05-14	Monthly	22	9.54%	8.31
AFG	Dividend Royal	2024-04-12	Bi-Monthly	39	9.39%	8.06
JPT	Dividend King	2023-11-02	Monthly	8	4.19%	8.05
VCIF	Dividend Royal	2023-08-18	Monthly	6	8.05%	8.02
EDI	Dividend Royal	2023-12-07	Monthly	13	8.85%	7.94

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.178	1.500	6.44	9.66	[0 - 0.5]
returnOnAssetsTTM	0.0953	1.200	6.82	8.19	[0 - 0.3]
returnOnEquityTTM	0.350	1.500	7.22	10.00	[0.1 - 1]
payoutRatioTTM	0.222	-1.000	7.78	-7.78	[0 - 1]
currentRatioTTM	1.477	0.800	7.62	6.09	[1 - 3]
quickRatioTTM	0.880	0.800	9.53	7.62	[0.8 - 2.5]
cashRatioTTM	0.475	1.500	8.47	10.00	[0.2 - 2]
debtRatioTTM	0.494	-1.500	1.767	-2.65	[0 - 0.6]
interestCoverageTTM	1.235	1.000	-0.654	-0.654	[3 - 30]
operatingCashFlowPerShareTTM	2.78	2.00	9.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.406	2.00	9.30	10.00	[0 - 20]
debtEquityRatioTTM	1.679	-1.500	3.28	-4.92	[0 - 2.5]
grossProfitMarginTTM	0.339	1.000	7.68	7.68	[0.2 - 0.8]
operatingProfitMarginTTM	0.0398	1.000	-1.204	-1.204	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.103	1.000	-0.540	-0.540	[0.2 - 2]
assetTurnoverTTM	0.536	0.800	9.76	7.81	[0.5 - 2]
Total Score				9.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	6.54	1.000	9.44	0	[1 - 100]
returnOnEquityTTM	0.350	2.50	8.21	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.406	2.00	9.53	10.00	[0 - 30]
dividendYielPercentageTTM	3.40	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.78	2.00	9.07	10.00	[0 - 30]
payoutRatioTTM	0.222	1.500	7.78	-7.78	[0 - 1]
pegRatioTTM	0.918	1.500	7.21	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0947	1.000	-0.133	0	[0.1 - 0.5]
Total Score				6.93

Baxter International Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.